BioCentury | Mar 12, 2019
Company News

Management tracks: Inovio, Sangamo, Innate

...pharmaceutical company Arecor Ltd. (Cambridge, U.K.) hired Susan Lowther as CFO. She was CFO of Ixico plc...
BioCentury | Feb 15, 2016
Finance

Imperial's diagnostic push

...plc (NASDAQ:OXFD) in 2012. Other diagnostic companies in the portfolio include Abingdon Health Ltd. and Ixico plc...
BioCentury | Nov 23, 2015
Financial News

Ixico proposes placing

Ixico plc (LSE:IXI), London, U.K. Business: Diagnostic, Supply/Service Date announced: 2015-11-18 Type: Placing To be raised: L2.7 million ($4.1 million) Shares: 8.9 million Price: 30.5p Shares outstanding prior: 15.2 million Placement agent: Peel Hunt Investors:...
BioCentury | Sep 22, 2014
Company News

Ixico management update

Ixico plc (LSE:IXI), London, U.K. Business: Diagnostic, Supply/Service Hired: Susan Lowther as CFO, effective Oct. 1, formerly CFO and a director of Novacyt S.A. WIR Staff Diagnostic...
BioCentury | Jul 31, 2014
Translation in Brief

Translational tidbits

...research on the diagnosis, prevention and treatment of AD and other dementias Araclon Biotech S.L.; Ixico plc...
BioCentury | Jul 24, 2014
Strategy

AD mission in the U.K.

...Dementias Research Platform MedImmune LLC; Janssen R&D LLC; GlaxoSmithKline plc (LSE:GSK; NYSE:GSK); Araclon Biotech S.L.; Ixico plc...
BioCentury | Jun 23, 2014
Company News

Araclon Biotech S.L, Ixico, SomaLogic, AstraZeneca, GlaxoSmithKline, J&J, Alzheimer’s Research U.K. neurology news

...the Janssen Research & Development LLC unit and London innovation center of Johnson & Johnson; Ixico...
...public after an undisclosed exclusivity period for consortium members. Araclon Biotech S.L ., Zaragoza, Spain Ixico plc...
BioCentury | Oct 21, 2013
Company News

Ixico, Phytopharm deal

...the resulting company, which is renamed Ixico plc (see BioCentury, Oct. 7). Ixico plc , London, U.K. Phytopharm...
BioCentury | Oct 7, 2013
Company News

Ixico, Phytopharm neurology news

...to issue an additional 465,350 shares. Ixico shareholders will receive 15.7 new shares for each Ixico...
...to Phytopharm shareholder approval at the general meeting scheduled for Oct. 14. Andy Richards, current Ixico...
...of Ixico Ltd., will also purchase additional shares and own 11.5% of the resulting company. Ixico...
BioCentury | May 27, 2013
Company News

Phytopharm neurology news

...revenue-generating, private UK-based company in the healthcare sector. The biotech said it would issue new Phytopharm...
...company's shareholders and that the proposed acquisition constitutes a reverse takeover under UK Listing Rules. Phytopharm...
...the acquisition. Phytopharm said heads of terms is similar to a term sheet. In March, Phytopharm...
Items per page:
1 - 10 of 208
BioCentury | Mar 12, 2019
Company News

Management tracks: Inovio, Sangamo, Innate

...pharmaceutical company Arecor Ltd. (Cambridge, U.K.) hired Susan Lowther as CFO. She was CFO of Ixico plc...
BioCentury | Feb 15, 2016
Finance

Imperial's diagnostic push

...plc (NASDAQ:OXFD) in 2012. Other diagnostic companies in the portfolio include Abingdon Health Ltd. and Ixico plc...
BioCentury | Nov 23, 2015
Financial News

Ixico proposes placing

Ixico plc (LSE:IXI), London, U.K. Business: Diagnostic, Supply/Service Date announced: 2015-11-18 Type: Placing To be raised: L2.7 million ($4.1 million) Shares: 8.9 million Price: 30.5p Shares outstanding prior: 15.2 million Placement agent: Peel Hunt Investors:...
BioCentury | Sep 22, 2014
Company News

Ixico management update

Ixico plc (LSE:IXI), London, U.K. Business: Diagnostic, Supply/Service Hired: Susan Lowther as CFO, effective Oct. 1, formerly CFO and a director of Novacyt S.A. WIR Staff Diagnostic...
BioCentury | Jul 31, 2014
Translation in Brief

Translational tidbits

...research on the diagnosis, prevention and treatment of AD and other dementias Araclon Biotech S.L.; Ixico plc...
BioCentury | Jul 24, 2014
Strategy

AD mission in the U.K.

...Dementias Research Platform MedImmune LLC; Janssen R&D LLC; GlaxoSmithKline plc (LSE:GSK; NYSE:GSK); Araclon Biotech S.L.; Ixico plc...
BioCentury | Jun 23, 2014
Company News

Araclon Biotech S.L, Ixico, SomaLogic, AstraZeneca, GlaxoSmithKline, J&J, Alzheimer’s Research U.K. neurology news

...the Janssen Research & Development LLC unit and London innovation center of Johnson & Johnson; Ixico...
...public after an undisclosed exclusivity period for consortium members. Araclon Biotech S.L ., Zaragoza, Spain Ixico plc...
BioCentury | Oct 21, 2013
Company News

Ixico, Phytopharm deal

...the resulting company, which is renamed Ixico plc (see BioCentury, Oct. 7). Ixico plc , London, U.K. Phytopharm...
BioCentury | Oct 7, 2013
Company News

Ixico, Phytopharm neurology news

...to issue an additional 465,350 shares. Ixico shareholders will receive 15.7 new shares for each Ixico...
...to Phytopharm shareholder approval at the general meeting scheduled for Oct. 14. Andy Richards, current Ixico...
...of Ixico Ltd., will also purchase additional shares and own 11.5% of the resulting company. Ixico...
BioCentury | May 27, 2013
Company News

Phytopharm neurology news

...revenue-generating, private UK-based company in the healthcare sector. The biotech said it would issue new Phytopharm...
...company's shareholders and that the proposed acquisition constitutes a reverse takeover under UK Listing Rules. Phytopharm...
...the acquisition. Phytopharm said heads of terms is similar to a term sheet. In March, Phytopharm...
Items per page:
1 - 10 of 208